Cybrexa Therapeutics
Cybrexa Therapeutics is a biotechnology company dedicated to developing a new class of tumor-targeted cancer therapies. The company is headquartered in New Haven, Connecticut.
Last updated on
About Cybrexa Therapeutics
Founded
2017Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$25MCategory
Industry
BiotechnologyLocation
City
New HavenState
ConnecticutCountry
United StatesCybrexa Therapeutics
Find your buyer within Cybrexa Therapeutics